Открыть главное меню
Главная
Случайная
Войти
Настройки
О hpluswiki
Отказ от ответственности
hpluswiki
Найти
Редактирование:
SYN1
Внимание:
Вы не вошли в систему. Ваш IP-адрес будет общедоступен, если вы запишете какие-либо изменения. Если вы
войдёте
или
создадите учётную запись
, её имя будет использоваться вместо IP-адреса, наряду с другими преимуществами.
Анти-спам проверка.
Не
заполняйте это!
Synapsin-1 (Brain protein 4.1) (Synapsin I) ==Publications== {{medline-entry |title=Aging alters the expression of neurotransmission-regulating proteins in the hippocampal synaptoproteome. |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/20374424 |abstract=Decreased cognitive performance reduces independence and quality of life for aging individuals. Healthy brain aging does not involve significant neuronal loss, but little is known about the effects of aging at synaptic terminals. Age-related cognitive decline likely reflects the manifestation of dysregulated synaptic function and ineffective neurotransmission. In this study, hippocampal synaptosomes were enriched from young-adult (3 months), adult (12 months), and aged (26 months) Fischer 344 x Brown Norway rats, and quantitative alterations in the synaptoproteome were examined by 2-DIGE and MS/MS. Bioinformatic analysis of differentially expressed proteins identified a significant effect of aging on a network of neurotransmission-regulating proteins. Specifically, altered expression of [[DNM1]], [[HPCA]], PSD95, [[SNAP25]], STX1, [[SYN1]], [[SYN2]], [[SYP]], and [[VAMP2]] was confirmed by immunoblotting. 14-3-3 isoforms identified in the proteomic analysis were also confirmed as a result of their implication in the regulation of the synaptic vesicle cycle and neurotransmission modulation. The findings of this study demonstrate a coordinated down-regulation of neurotransmission-regulating proteins that suggests an age-based deterioration of hippocampal neurotransmission occurring between adulthood and advanced age. Altered synaptic protein expression may decrease stimulus-induced neurotransmission and vesicle replenishment during prolonged or intense stimulation, which are necessary for learning and the formation and perseverance of memory. |mesh-terms=* Aging * Animals * Computational Biology * Electrophoresis, Gel, Two-Dimensional * Gene Expression Regulation * Hippocampus * Male * Mass Spectrometry * Membrane Proteins * Microscopy, Electron, Transmission * Proteome * Rats * Rats, Inbred F344 * Synaptic Transmission * Synaptosomes |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3010414 }} {{medline-entry |title=Effects of lifelong intervention with an oligofructose-enriched inulin in rats on general health and lifespan. |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/18405402 |abstract=Ageing is associated with changes in physiology and morphology; nutritional strategies to decrease morbidity and to prolong life are of high interest. The aim of the study was to investigate the effects of lifelong supplementation with an oligofructose-enriched inulin on morphological and biological markers and lifespan in male and female rats. Male and female rats, age 3 months, were randomised into two groups to receive either a diet with 10 % of an oligofructose-enriched inulin (Synergy 1) or a standard diet (control) for 27 months. The rats were weighed every 2 weeks and their food intake was evaluated on four successive days every 4-6 weeks. Samples were taken at 12, 18 and 24 months of age. During the whole intervention period, male rats receiving Synergy 1 ([[SYN1]]-M) displayed lower body weight, cholesterol and plasma triacylglycerolaemia compared with the controls (Cont-M). The survival rate at 24 months of age of [[SYN1]]-M rats was 35.3 % greater than that of Cont-M rats. In female rats, the Synergy 1 supplementation ([[SYN1]]-F) group also reduced body weight, cholesterol and triacylglycerolaemia levels, but results were less consistent over the experiment. The survival rate at 24 months of age in [[SYN1]]-F rats was 33.3 % greater compared with that of the control (Cont-F) group. To conclude, lifelong intervention with Synergy 1 improved biological markers during ageing and survival rate (lifespan) of rats. |mesh-terms=* Aging * Animals * Biomarkers * Blood Glucose * Body Composition * Cholesterol * Drug Evaluation, Preclinical * Eating * Female * Inulin * Lipid Metabolism * Longevity * Male * Oligosaccharides * Rats * Rats, Sprague-Dawley * Triglycerides * Weight Gain |full-text-url=https://sci-hub.do/10.1017/S0007114508975607 }}
Описание изменений:
Пожалуйста, учтите, что любой ваш вклад в проект «hpluswiki» может быть отредактирован или удалён другими участниками. Если вы не хотите, чтобы кто-либо изменял ваши тексты, не помещайте их сюда.
Вы также подтверждаете, что являетесь автором вносимых дополнений, или скопировали их из источника, допускающего свободное распространение и изменение своего содержимого (см.
Hpluswiki:Авторские права
).
НЕ РАЗМЕЩАЙТЕ БЕЗ РАЗРЕШЕНИЯ ОХРАНЯЕМЫЕ АВТОРСКИМ ПРАВОМ МАТЕРИАЛЫ!
Отменить
Справка по редактированию
(в новом окне)
Шаблон, используемый на этой странице:
Шаблон:Medline-entry
(
править
)